All news

Tonix Pharmaceuticals CEO purchases shares near yearly low

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Tonix Pharmaceuticals Chief Executive Seth Lederman purchased 5,000 common shares for $20,275 with the stock trading near 52-week lows. The purchase followed mixed third-quarter earnings featuring revenue beating expectations alongside a larger loss per share. For investors, insider buying at depressed valuation levels often signals executive confidence despite wider quarterly losses.

Read original source

TNXP company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.